Cargando…
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
BACKGROUND: Previous study demonstrated that miR-133a was released into blood from injured myocardium in cardiovascular diseases. However, the dynamic change of circulating miR-133a level in the early phase of acute myocardial infarction (AMI) and the correlation between miR-133a and severity of cor...
Autores principales: | Wang, Feng, Long, Guangwen, Zhao, Chunxia, Li, Huaping, Chaugai, Sandip, Wang, Yan, Chen, Chen, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849017/ https://www.ncbi.nlm.nih.gov/pubmed/24053180 http://dx.doi.org/10.1186/1479-5876-11-222 |
Ejemplares similares
-
Atherosclerosis-Related Circulating miRNAs as Novel and Sensitive Predictors for Acute Myocardial Infarction
por: Wang, Feng, et al.
Publicado: (2014) -
Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans
por: Long, Guangwen, et al.
Publicado: (2013) -
MicroRNA-133a and Myocardial Infarction
por: Xiao, Yi, et al.
Publicado: (2019) -
Human Circulating MicroRNA-1 and MicroRNA-126 as Potential Novel Indicators for Acute Myocardial Infarction
por: Long, Guangwen, et al.
Publicado: (2012) -
MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2017)